Detalles de la búsqueda
1.
Safety and Efficacy of 25 mg/kg and 35 mg/kg vs 10 mg/kg Rifampicin in Pulmonary TB: A Phase IIb Randomized Controlled Trial.
Open Forum Infect Dis
; 11(3): ofae034, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38444824
2.
Predictors of mortality among hospitalized COVID-19 patients and risk score formulation for prioritizing tertiary care-An experience from South India.
PLoS One
; 17(2): e0263471, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35113971
3.
Drug susceptibility profiling of pulmonary Mycobacterium kansasii and its correlation with treatment outcome.
Ann Thorac Med
; 16(4): 323-328, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34820019
4.
Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden.
PLoS One
; 16(9): e0257647, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543329
5.
Characteristics of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and its influence on tuberculosis treatment outcomes in persons living with HIV.
Int J Infect Dis
; 98: 261-267, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32623087
6.
Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial.
JAMA Intern Med
; 178(4): 485-493, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29507938
7.
Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV.
PLoS One
; 11(9): e0163298, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27643598
8.
9.
Resultados
1 -
9
de 9
1
Próxima >
>>